Quarter Financials
Monopar Therapeutics Inc. (MNPR)
$2.48
-0.02 (-0.80%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -2 | -3 | -2 | -9,103,218 | -2 | -2 | -2 | -2 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -49 | -47 | -44 | -41 | -39 | -36 | -34 | -32 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | 0 | 0 | 0 | - | - | - | - | - |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|